Silo Pharma, Inc.

The momentum for this stock is not very good. Silo Pharma, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Silo Pharma, Inc..

News

Silo Pharma announces global license for its PTSD and anxiety disorder treatment drug

Seeking Alpha - Healthcare Silo Pharma announces global license for its PTSD and anxiety disorder treatment drug...\n more…

Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders

Globe Newswire Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ( Silo or the Company ), a...\n more…

Silo Pharma, AmplifyBio partner to advance SPC-15 for PTSD, anxiety

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Globe Newswire Amplify Bio to complete GLP study of SPC-15 Novel Intranasal Therapeutic Silo study advances SPC-15 towards first-in-human trial SARASOTA, FL, June 26, 2024 (GLOBE NEWSWIRE) -- Silo...\n more…

Silo Pharma announces successful production of its SP-26 ketamine implant

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Globe Newswire Analytical testing has confirmed optimal formulation for upcoming studies SARASOTA, FL, June 07, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ( Silo or the Company ), a...\n more…